← All Sponsors
SPONSOR

A&G Pharmaceutical Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Triple Negative Breast CancerHormone-Resistant Breast CancerNon Small Cell Lung CancerMesothelioma
NCT05627960 Phase 1
Recruiting

First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

Triple Negative Breast Cancer
United States View Trial →